ACTRN12624000835549尚未招募Unknown
Evaluating a co-designed shared care model of care on the quality of life of patients accessing gender affirming hormone therapy
niversity of Melbourne0 个研究点目标入组 234 人开始时间: 2024年7月5日最近更新:
适应症
试验速览
- 阶段
- Unknown
- 状态
- 尚未招募
- 发起方
- 入组人数
- 234
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Non-randomised trial
- 主要目的
- Treatment
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 16 Years 至 o limit(—)
- 性别
- All
入选标准
- •1. Currently residing in rural or remote Victoria (Modified Monash Model Remoteness Areas 2 – 7)
- •2.Aged 18 years or over
- •3.Aged 16 – 17 and have both parents provide informed consent for the initiation of gender affirming hormone therapy and participation.
- •4.Have a gender that is different from what was recorded at birth (i.e. transgender or gender diverse), including binary and non-binary gender identities, or cultural gender identities
- •5.Have been referred to a Gender Clinic for commencement of gender affirming hormone therapy
- •6.Have capacity to provide informed consent
- •7.Able to understand and complete questionnaires
- •; 1. Currently residing in rural or remote Victoria (Modified Monash Model Remoteness Areas 2 – 7)
- •2.Aged 18 years or over
- •3.Aged 16 – 17 and have both parents provide informed consent for the initiation of gender affirming hormone therapy and participation.
- •4.Have a gender that is different from what was recorded at birth (i.e. transgender or gender diverse), including binary and non-binary gender identities, or cultural gender identities
- •5.Have been referred to a Gender Clinic for commencement of gender affirming hormone therapy
- •6.Have capacity to provide informed consent
- •7.Able to understand and complete questionnaires
排除标准
- •- aged under 16 years
- •- have a gender that is congruent with what was presumed for them at birth (i.e. cisgender); - aged under 16 years
- •- have a gender that is congruent with what was presumed for them at birth (i.e. cisgender)
研究者
相似试验
招募中
不适用
Pilot testing of a collaborative Shared Care Model for Detecting Neurodevelopmental Impairments after Critical Illness in Young Childreeurodevelopmental ImpairmentsPost Intensive Care Syndrome - PediatricsNeurodevelopmental ImpairmentsNeurological - Other neurological disordersACTRN12621000799853Queensland University of Technology149
已完成
不适用
The effect of collaborative care model on self-efficacy of MS patients.Multiple Sclerosis.Demyelinating diseases of the central nervous systemIRCT2013021212248N2Ahvaz Jundishapur University of Medical Science80
已完成
不适用
Evaluating the Effect of a Shared Care Pathway Intervention on Unplanned Presentations to Hospital by Chemotherapy OutpatientsCancerACTRN12614001113640The University of Sydney353
Unknown
不适用
Development, Implementation and Evaluation of a Complex Regional Intervention for Type 2 Diabetes: Diabetes Project AalstDiabetes Type 2NCT00824499Universiteit Antwerpen375
已完成
不适用
The effect of collaborative care model on lifestyle of multiple sclerosis patientsMULTIPLE SCLEROSIS.Acute transverse myelitis in demyelinating disease of central nervous systemIRCT2013012312248N1Ahvaz Jundishapur University of Medical Science80
